Tsumura & Co. (TSMRF)
Tsumura & Co. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Tokyo, TY, JP. The stock last traded at $23.20, up 0.00% on the session, giving a market capitalisation of $1.73B. On trailing twelve-month figures it carries a trailing P/E of 9.24, a net margin of 15.2%. Its beta of 0.07 implies it has historically moved less than the broad market.
Tsumura & Co. is a global pharmaceutical company specializing in the production and distribution of various medicinal products. Their core offerings include Kampo extract intermediates and granular Kampo formulations. The company manages the comprehensive process of bringing these traditional remedies to market, from the sourcing, meticulous selection, and processing of raw herbal ingredients to their careful warehousing, including components prepared for traditional decoctions. Tsumura & Co. also manufactures powdered Kampo extracts and a range of traditional Chinese medical preparations. Beyond pharmaceuticals, the company additionally distributes food items. Established in 1893, Tsumura & Co. maintains its headquarters in Tokyo, Japan.
Tsumura & Co. is most often compared with the following Healthcare names: